258 related articles for article (PubMed ID: 25728269)
1. Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani.
Wright MH; Paape D; Storck EM; Serwa RA; Smith DF; Tate EW
Chem Biol; 2015 Mar; 22(3):342-54. PubMed ID: 25728269
[TBL] [Abstract][Full Text] [Related]
2. Chemical proteomics versus leishmaniasis.
Ehrmann M; Kaschani F; Kaiser M
Chem Biol; 2015 Mar; 22(3):309-10. PubMed ID: 25794432
[TBL] [Abstract][Full Text] [Related]
3. N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.
Brannigan JA; Smith BA; Yu Z; Brzozowski AM; Hodgkinson MR; Maroof A; Price HP; Meier F; Leatherbarrow RJ; Tate EW; Smith DF; Wilkinson AJ
J Mol Biol; 2010 Mar; 396(4):985-99. PubMed ID: 20036251
[TBL] [Abstract][Full Text] [Related]
4. Profiling of myristoylation in
Broncel M; Dominicus C; Vigetti L; Nofal SD; Bartlett EJ; Touquet B; Hunt A; Wallbank BA; Federico S; Matthews S; Young JC; Tate EW; Tardieux I; Treeck M
Elife; 2020 Jul; 9():. PubMed ID: 32618271
[TBL] [Abstract][Full Text] [Related]
5. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
6. Novel Thienopyrimidine Inhibitors of
Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985
[TBL] [Abstract][Full Text] [Related]
7. Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model.
Paape D; Prendergast CT; Price HP; Doehl JSP; Smith DF
Parasit Vectors; 2020 Mar; 13(1):132. PubMed ID: 32171322
[TBL] [Abstract][Full Text] [Related]
8. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.
Corpas-Lopez V; Moniz S; Thomas M; Wall RJ; Torrie LS; Zander-Dinse D; Tinti M; Brand S; Stojanovski L; Manthri S; Hallyburton I; Zuccotto F; Wyatt PG; De Rycker M; Horn D; Ferguson MAJ; Clos J; Read KD; Fairlamb AH; Gilbert IH; Wyllie S
ACS Infect Dis; 2019 Jan; 5(1):111-122. PubMed ID: 30380837
[TBL] [Abstract][Full Text] [Related]
10. Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite
Wright MH; Paape D; Price HP; Smith DF; Tate EW
ACS Infect Dis; 2016 Jun; 2(6):427-441. PubMed ID: 27331140
[TBL] [Abstract][Full Text] [Related]
11. New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness.
Ritzefeld M; Wright MH; Tate EW
Parasitology; 2018 Feb; 145(2):157-174. PubMed ID: 28270257
[TBL] [Abstract][Full Text] [Related]
12. A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani.
Pawar H; Sahasrabuddhe NA; Renuse S; Keerthikumar S; Sharma J; Kumar GS; Venugopal A; Sekhar NR; Kelkar DS; Nemade H; Khobragade SN; Muthusamy B; Kandasamy K; Harsha HC; Chaerkady R; Patole MS; Pandey A
Proteomics; 2012 Mar; 12(6):832-44. PubMed ID: 22539434
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
[TBL] [Abstract][Full Text] [Related]
14. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival.
Biyani N; Madhubala R
Biochim Biophys Acta; 2012 Dec; 1824(12):1342-50. PubMed ID: 22850196
[TBL] [Abstract][Full Text] [Related]
16. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):541-57. PubMed ID: 11955008
[TBL] [Abstract][Full Text] [Related]
17. N-myristoylation: from cell biology to translational medicine.
Yuan M; Song ZH; Ying MD; Zhu H; He QJ; Yang B; Cao J
Acta Pharmacol Sin; 2020 Aug; 41(8):1005-1015. PubMed ID: 32203082
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.
Raju RV; Sharma RK
Mol Cell Biochem; 1996 May; 158(2):107-13. PubMed ID: 8817471
[TBL] [Abstract][Full Text] [Related]
19. Use of alkyne-tagged myristic acid to detect N-terminal myristoylation.
Xu Y; Lin H
Methods Enzymol; 2023; 684():191-208. PubMed ID: 37230589
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.
Hutton JA; Goncalves V; Brannigan JA; Paape D; Wright MH; Waugh TM; Roberts SM; Bell AS; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
J Med Chem; 2014 Oct; 57(20):8664-70. PubMed ID: 25238611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
